Stockwinners Market Radar for May 02, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EDT Yield10 Bioscience trading halted, news pending

19:02 EDT Tidewater board approves additional buyback of $18.1M - Tidewater board approves additional share repurchase authorization of $18.1 million, for a total outstanding authorization of $50.7 million, the maximum permissible amount under existing debt agreements.

18:42 EDT Forum Energy affirms FY24 adjusted EBITDA view of $100M-$120M - Affirms FY24 free cash flow view of $40M-$60M.

18:16 EDT Enphase Energy CFO buys $417K in common stock - In a regulatory filing, Enphase Energy disclosed that its CFO Mandy Yang bought 4K shares of common stock on May 2nd in a total transaction size of $417K.

17:58 EDT Apple sees Q3 gross margin 45.5%-46.5% - Expects memory, FX to be 'slight headwind.'

17:37 EDT Terran Orbital says strategic review ongoing - The company states: "Terran Orbital confirms its ongoing strategic review to maximize shareholder value. The review allows us to explore all options."

17:28 EDT Northrop Grumman awarded $7B Air Force contract - Northrop Grumman was awarded an indefinite-delivery/indefinite-quantity contract with a ceiling of $7B for B-2 modernization and sustainment. This contract provides for B-2 enhancements, sustainment, logistics elements including sustaining engineering, software maintenance, and support equipment. Also included is programmed depot maintenance of the fleet and other interim contractor support. Work is expected to be completed by May 3, 2029. This contract was a sole source acquisition. FY23 research, development, test, and evaluation funds in the amount of $21,439 are being obligated at time of award. The Air Force Life Cycle Management Center is the contracting activity.

17:26 EDT Terreno Realty acquires multi-city portfolio for $364.5M - Terreno Realty acquired a portfolio of industrial properties located in New York City, Northern New Jersey, San Francisco Bay Area, and Los Angeles for a purchase price of approximately $364.5M. The portfolio of 28 buildings containing approximately 1.2M square feet is 91.6% leased to 70 tenants. The in-place cap rate is 4.3%, the estimated stabilized cap rate is 5.0% and the estimated stabilized cap rate adjusting to today's market rents is 5.8%.

17:22 EDT Apple says 'particularly pleased' with momentum in emerging markets - Plans for annual dividend increases going forward.

17:13 EDT Apple says set revenue records in a dozen countries in Q2 - Says making "significant investments" in in generative AI and "very bullish" on the opportunities they present. Says iPhone grew in mainland China. Comments taken from Q2 earnings conference call.

17:07 EDT Sandstorm Gold still sees 2024 production 75K-90K attributable gold eq. oz.

17:02 EDT Progress Software does not intend to make an offer for MariaDB - Progress Software Corp. confirmed that it does not intend to make an offer for MariaDB plc. Accordingly, Progress will be bound by the restrictions set out in Rule 2.8 of the Irish Takeover Rules. Progress reserves the right within the next 6 months to set aside this statement where so permitted under Rule 2.8.

16:59 EDT Booking Holdings sees Q2 gross bookings growth up 3%-5% - Comments taken from Q1 earnings conference call.

16:54 EDT Booking Holdings sees Q2 revenue growth up 4%-6%, consensus $5.78B - Sees Q2 room nights growth of 4%-6%. Sees Q2 adjusted EBITDA $1.70B-$1.75B. Comments taken from Q1 earnings conference call.

16:47 EDT BLET chairmen say Norfolk Southern CEO 'falsely accusing' Ancora - The three Brotherhood of Locomotive Engineers and Trainmen General Chairmen, Scott Bunten, Dewayne Dehart, and Jerry Sturdivant, who are affiliated with the International Brotherhood of Teamsters and represent members at Norfolk Southern Corporation the following statement: "Norfolk Southern CEO Alan Shaw is falsely accusing Ancora and two out of the three largest rail unions - the BLET and the BMWED, who collectively represent 41.5% of the railroad's unionized workforce - of violating the Railway Labor Act and negotiating 'backroom deals' at the expense of shareholders. Mr. Shaw chose to ignore the fact that both unions are not only stakeholders, but each also represents large numbers of shareholders, who want to see the company succeed. He made his ungrounded and desperate claims after it became public that positive discussions were held between Ancora nominees with officers of the two Teamsters affiliates. In another act of desperation, Norfolk Southern issued a press release misrepresenting the record of Jim Barber, an Ancora nominee and long-time partner to unions. Mr. Barber has not only demonstrated positive relationships with labor here, but also had direct experience driving productive engagement with the Teamsters while COO and President of International at UPS. In fact, the largest private sector collective bargaining agreement in the United States is the UPS-Teamsters National Master Agreement. Desperate statements and inconsistent and shifting strategies characterized much of what BLET's union leaders have heard from Norfolk Southern's current CEO in recent weeks. This is why BLET's leaders chose to switch their support to Ancora after meeting with Mr. Barber and its nominees. We suspect this is why other investors and rail unions are likely to follow." Scott Bunten, Dewayne Dehart, and Jerry Sturdivant, the three General Chairmen representing BLET members at Norfolk Southern, made this additional joint statement: "Although we initially supported Mr. Shaw and Norfolk Southern's management in this contest, today he leads a different team with an unproven strategy. The ever-changing and inconsistent policies that we have been hearing from the railroad's current leadership in recent weeks forced BLET to take another look at Ancora and its nominees. We ultimately made a final decision to support the Ancora slate and CEO choice. Alan Shaw's unfounded attacks this week have further convinced us that we made the correct choice."

16:35 EDT Camden Property sees FY24 core FFO $6.62-$6.86, consensus $6.72 - The company said: "We have revised our 2024 outlook for property operating expense growth downward from 4.50% to 3.25% at the midpoint of our guidance range as a result of favorable real estate tax valuations, lower core insurance claims, and the successful renewal of our insurance policies on May 1st. However, given the recent rise in interest rates and lowered odds of future rate cuts this year, we expect to incur higher than anticipated interest expense for the remainder of the year. As a result of these events, we are maintaining our full-year 2024 guidance of $6.74 per share for Core FFO at the midpoint of our range."

16:34 EDT Apple reports Q2 Services revenue $23.87B vs. $20.91B last year

16:33 EDT Apple reports Q2 iPad revenue $5.56B vs. $6.67B last year

16:33 EDT Apple reports Q2 iPhone revenue $45.96B vs. $51.33B last year

16:31 EDT Apple raises dividend 4%, announces $110B buyback boost - Apple's board has declared a cash dividend of 25c per share of the company's common stock, an increase of 4%. The dividend is payable on May 16, to shareholders of record as of the close of business on May 13. The board also authorized an additional program to repurchase up to $110B of the company's common stock.

16:28 EDT Alamo Group says outlook for balance of 2024 'somewhat more cautious' - Given the mixed market conditions we experienced in the first quarter, we were pleased with the results reported today. As we expected, substantially improved performance in Industrial Equipment largely offset the impact of the headwinds in Vegetation Management. Our outlook for the balance of 2024 is, however, somewhat more cautious than it was when we reported results for the fourth quarter of 2023, given the uncertain interest rate environment. While this is not expected to impact the positive momentum and favorable results from our Industrial Equipment Division, it will likely prolong the current headwinds in Vegetation Management for the balance of the year and delay the anticipated correction in channel inventory. We will therefore continue to take determined actions to defend operating margin for the balance of 2024. We also believe that the Company's results for the first quarter nicely highlight the strength of our brands, the resilience of our broad product portfolio and the diverse markets we serve. We remain focused on efficiently executing our long-term strategy, and therefore remain optimistic about the Company's future prospects."

16:26 EDT Floor & Decor reports Q1 SSS down 11.6%

16:22 EDT SM Energy sees Q2 CapEx $315M-$325M - Capital expenditures (net of the change in capital accruals), excluding acquisitions: approximately $315-$325 million. In the second quarter of 2024, the company expects to drill approximately 31 net wells, of which 9 are planned for South Texas and 22 are planned for the Midland Basin, and turn-in-line approximately 38 net wells, of which 10 are planned for South Texas and 28 are planned for the Midland Basin. Production: Approximately 14.1-14.3 MMBoe or 155-157 MBoe/d, at approximately 44% oil and 60% liquids.

16:22 EDT SM Energy sees FY24 CapEx $1.14B-$1.18B - Full year guidance for net production is increased 2% at the mid-point to 57-60 MMBoe or 156-164 MBoe/d at ~44% oil. Full year guidance for capital expenditures (net of the change in capital accruals), excluding acquisitions, is reduced 2% at the mid-point to $1.14-$1.18 billion. Full year guidance for transportation expense per Boe is reduced 9% at the mid-point to $2.10-2.20 per Boe. Other line items remain unchanged.

16:18 EDT Block sees FY24 adjusted EBITDA $2.76B vs. prior view at least $2.63B

16:18 EDT Block sees Q2 adjusted EBITDA $670M-$690M - Sees Q2 gross profit $2.17B-$2.19B.

16:17 EDT Block reports Q1 GPV $54.43B

16:13 EDT Paylocity announces $500M share repurchase program - The Company's Board of Directors authorized the purchase of up to $500 million of its common stock. Shares will be repurchased from time to time in the open market or in privately negotiated transactions at the company's discretion, subject to market conditions and other factors, and in accordance with applicable regulatory requirements. The company may commence, suspend or discontinue purchases of common stock under the authorization at any time or periodically without prior notice.

16:08 EDT Coterra Energy sees FY24 incurred CapEx $1.75B-$1.95B - Increasing 2024 oil production guidance to 102 to 107 MBopd, up 2.5% at the mid-point versus prior guidance. Expect second-quarter 2024 total equivalent production of 625 to 655 MBoepd, oil production of 103 to 107 MBopd, natural gas production of 2,600 to 2,700 MMcfpd, and incurred capital expenditures (non-GAAP) of $470 to $550 million. Estimate 2024 Discretionary Cash Flow (non-GAAP) of approximately $3.1 billion and 2024 Free Cash Flow (non-GAAP) of approximately $1.3 billion, at $79/bbl WTI and $2.35/mmbtu average NYMEX assumptions.

16:03 EDT Booking Holdings up 4% after Q1 report - Shares of Booking Holdings are up $148.97, or 4%, to $3,621.88 in after-hours trading following the company's Q1 report.

15:13 EDT Atlantica Sustainable up 4% after Bloomberg report on takeover talks - Atlantica Sustainable Infrastructure shares are up 87c, or 4%, to $21.79 following Bloomberg's reports on takeover talks with Energy Capital Partners.

13:59 EDT Napco Security names CFO Kevin Buchel as COO as well - Napco Security announced Kevin Buchel has been promoted to President and Chief Operating Officer while maintaining his position as Chief Financial Officer. Michael Carrieri has been promoted to Executive Vice President of Engineering and Chief Technology Officer, while Andrew Vuono was appointed as the company's Senior Vice President of Finance and Chief Accounting Officer. Napco Founder, Richard Soloway, who will continue under his present titles of Chairman and CEO, commented: "Kevin has been with NAPCO for 30 years in various management positions, most recently as our Executive VP and CFO. The appointment of Kevin as President & COO is well-deserved, and comes at an exciting time at NAPCO as we continue to grow both revenues and our earning metrics... Michael has been our Senior Vice President of Engineering Development for the past 24 years. With his skills in creating products from various in-house and external sources, he and the prolific engineering team that he has developed have been instrumental in NAPCO's substantial growth over so many years. Those products are the most diversified range of products in the security industry and bode well for substantial corporate growth going forward."

13:12 EDT Intuit appoints Vasant Prabhu, former CFO of Visa, to board - Intuit (INTU) announced that it appointed Vasant Prabhu, former Chief Financial Officer and Vice Chairman of Visa (V), to its board of directors. "We are excited to welcome Vasant to our board. He has deep expertise in financial services innovation and building a global technology and payments platform," said Sasan Goodarzi, CEO of Intuit. "His leadership experience as CFO of large public companies, expanding financial technology and services, and scaling businesses internationally, will help guide Intuit's next chapter of growth as we power prosperity around the world."

12:01 EDT Carvana rises 35.4% - Carvana is up 35.4%, or $30.86 to $117.95.

12:01 EDT Emergent BioSolutions rises 113.2% - Emergent BioSolutions is up 113.2%, or $2.19 to $4.12.

12:00 EDT Fastly falls -33.6% - Fastly is down -33.6%, or -$4.34 to $8.59.

11:12 EDT Vestis Corp trading resumes

10:10 EDT Kohl's joins forces with Instacart for same-day delivery - Kohl's (KSS) is now on the Instacart (CART) App, enabling nearly 109 million U.S. households to enjoy same-day delivery in as fast as an hour from 1,172 Kohl's stores across the U.S., the companies announced. "This partnership gives customers access to a wide array of products, including accessories, home essentials, premium skincare, beauty items, pet supplies, and much more," they said, adding that "As Kohl's exclusive same-day delivery partner, customers on Instacart can quickly place orders for either same-day or scheduled delivery, enjoying the same prices as in-store. Plus, customers shopping at Kohl's on Instacart can still earn their Kohl's Rewards." "With Kohl's as one of the first department stores on our platform, we're proud to continue expanding our selection beyond grocery, making everyday shopping for our customers easier for their busy lives," said Blake Wallace, Senior Director, Retail Partnerships at Instacart. "We're committed to offering customers a broad selection of items and ways to get exactly what they need from the retailers they know and love." Reference Link

10:03 EDT America's Car-Mart to acquire Texas Auto Center, terms not disclosed - America's Car-Mart has entered into a definitive agreement to purchase the dealership assets of Texas Auto Center. The transaction, which excludes legacy finance receivables, is expected to close in the first quarter of Car-Mart's 2025 fiscal year, which begins May 1, 2024.

10:01 EDT Vestis falls -31.3% - Vestis is down -31.3%, or -$5.78 to $12.69.

10:00 EDT Carvana rises 32.9% - Carvana is up 32.9%, or $28.61 to $115.70.

10:00 EDT Emergent BioSolutions rises 65.3% - Emergent BioSolutions is up 65.3%, or $1.26 to $3.19.

09:49 EDT Bite Acquisition Corp trading resumes

09:47 EDT Aspen Aerogels rises 34.4% - Aspen Aerogels is up 34.4%, or $5.24 to $20.45.

09:47 EDT Wolfspeed falls -11.2% - Wolfspeed is down -11.2%, or -$2.93 to $23.18.

09:47 EDT Fastly falls -38.5% - Fastly is down -38.5%, or -$4.97 to $7.96.

09:45 EDT FTC bans former Pioneer CEO from Exxon board seat in Exxon-Pioneer deal - The Federal Trade Commission took action to resolve antitrust concerns surrounding Exxon Mobil Corporation's (XOM) $64.5B acquisition of oil producer Pioneer Natural Resources (PXD) by approving a consent order that prevents founder and former Pioneer CEO Scott Sheffield from gaining a seat on Exxon's board of directors or serving in an advisory capacity at Exxon once it acquires Pioneer. The proposed consent order seeks to prevent Pioneer's Sheffield from engaging in collusive activity that would potentially raise crude oil prices, leading American consumers and businesses to pay higher prices for gasoline, diesel fuel, heating oil and jet fuel. The FTC alleges in a complaint that Sheffield has, through public statements and private communications, attempted to collude with the representatives of the Organization of Petroleum Exporting Countries and a related cartel of other oil-producing countries known as OPEC+ to reduce output of oil and gas, which would result in Americans paying higher prices at the pump, to inflate profits for his company. "Mr. Sheffield's past conduct makes it crystal clear that he should be nowhere near Exxon's boardroom. American consumers shouldn't pay unfair prices at the pump simply to pad a corporate executive's pocketbook," said Kyle Mach, Deputy Director of the FTC's Bureau of Competition. "The FTC will remain vigilant in its enforcement efforts to protect competition in these vital markets." The FTC's proposed consent order would prohibit Exxon from nominating, designating, or appointing Sheffield to the Exxon board or from serving in an advisory capacity in any way to the Exxon board or Exxon's management. Reference Link

09:41 EDT Mobile-Health Network Solutions trading halted, volatility trading pause

09:37 EDT Pioneer Natural says 'disagree and are surprised by' FTC's complaint - Pioneer Natural Resources (PXD) issued the following statement in response to the decision by the U.S. Federal Trade Commission to clear the proposed merger with Exxon Mobil (XOM) subject to a consent order based on allegations in a settlement complaint directed at Mr. Sheffield: "We disagree and are surprised by the FTC's Complaint saying that Mr. Sheffield's record and statements on matters of public interest should disqualify him from serving on the ExxonMobil Board of Directors. Notwithstanding, Pioneer and Mr. Sheffield are not taking any steps to prevent the merger from closing. As he has for his entire career, Mr. Sheffield is electing to place the interests of investors, employees and the competitive health of the U.S. energy industry ahead of his own. At the same time, Mr. Sheffield and Pioneer believe that the FTC's Complaint reflects a fundamental misunderstanding of the U.S. and global oil markets and misreads the nature and intent of Mr. Sheffield's actions. During Mr. Sheffield's career, it was neither the intent nor an effect of Mr. Sheffield's communications to circumvent the laws and principles protecting market competition... Over the course of his 50-year career, Mr. Sheffield has been at the forefront of building a competitive U.S. shale industry, which comprises scores of public and private independent companies... He has been a champion of building a competitive industry labor market, improving skills and opportunities and an advocate for fostering an employee culture rooted in respect, integrity, safety, diversity and collaboration."

09:35 EDT Kemper trading halted, volatility trading pause

09:35 EDT NETGEAR trading resumes

09:30 EDT NETGEAR trading halted, volatility trading pause

09:25 EDT Kellanova: Margin expansion ahead of pace

09:24 EDT Kellanova notes 'increased confidence' in FY24 guidance - Comments taken from Q1 earnings conference call presentation slides.

09:22 EDT Immunome appoints Kinney Horn as chief business officer - Immunome announced the appointment of Kinney Horn as chief business officer. Horn brings to Immunome extensive experience across life sciences corporate and business development, alliance management, and commercial strategy.

09:20 EDT Peloton says most cost reductions to take effect immediately - Sees opportunities to scale back media spend. Plans to be much more targeted, efficient with marketing spend. Says focus will be on new markets. Sees lots of "untapped potential" from International markets. Says "confident" in ability to continue to generate positive free cash flow.

09:20 EDT Inspira Technologies announces start of production of Inspira ART100 - Inspira Technologies announced the start of production of the Inspira ART100 medical device. The Inspira ART100 device is being contract manufactured by a leading technology company that provides high-technology electronic assembly solutions for the medical, aero-space and aviation, communications and defense industries. The manufacturer has commenced with the production and assembly of the first batch of Inspira ART100 devices, which will be used for deployment in several initial sites, subject to FDA regulatory clearance.

09:19 EDT Crown Electrokinetics announces new fiber construction customer - Crown Electrokinetics has secured a project in Idaho for horizontal drilling work as a prime contractor with Fat Beam Fiber. The large fiber to the home project is anticipated to commence immediately where it is expected to continue throughout the calendar year, likely resulting in additional work in both California and Oregon.

09:17 EDT Jack in the Box's Del Taco opens 8th location in Florida - Del Taco announced the opening of its new Fresh Flex location at 2760 S. Hwy 331. It is the second restaurant for franchise organization, Consolidated Taco Holdings, and uses the all-new Fresh Flex layout, which features a bold, modernized design and innovative layout changes to optimize the guest experience. "Following the incredible response to our Santa Rosa Beach location, we're thrilled to build on our growth with the opening of our second Del Taco restaurant in DeFuniak Springs," said a spokesperson for Consolidated Taco Holdings. "We can't wait to introduce locals to Del Taco's popular Mexican and American favorites in an elevated environment that enhances the dine-in and drive-thru experience."

09:11 EDT American Rebel receives license to distribute American Rebel Beer in Kansas - American Rebel Holdings announces their receipt of a license from the state of Kansas to distribute beer within the state through its distribution agreement with Standard Beverage Corporation. "We're very excited to have our license and our distribution agreement to sell American Rebel Beer throughout the state of Kansas," said Andy Ross, Chief Executive Officer of American Rebel. "We already have a great relationship with our Kansas distributor, Standard Beverage, along with commitments from the top sports bars in the state, as well as retail outlets, venues and Kansas-based music festivals. Launching America's Patriotic, God-Fearing, Constitution-Loving, National Anthem Singing, Stand Your Ground Beer into the marketplace is a primary goal of our current Reg A+ offering and having American Rebel Light Beer available in the state of Tennessee helps deliver on that goal. Interested investors 18 years or older can log onto our public offering website at http://invest.americanrebel.com and subscribe to the offering."

09:11 EDT Park Hotels & Resorts announces tender offer for senior notes - Park Hotels & Resorts commenced a tender offer to purchase for cash, subject to certain terms and conditions, any and all of their outstanding 7.500% Senior Notes due 2025. The Tender Offer is scheduled to expire at 5:00 p.m., New York City time, on May 13, 2024, unless extended or earlier terminated by the Issuers. The Tender Offer is being made pursuant to an Offer to Purchase and related Notice of Guaranteed Delivery, each dated May 2, 2024.

09:08 EDT Nuwellis receives USPTO notice of patent allowance for CRRT technology - Nuwellis announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office, USPTO, for a patent application related to its innovative pediatric Continuous Renal Replacement Therapy, CRRT, device branded Vivian. This patent strengthens Nuwellis' intellectual property portfolio and paves the way for the development of novel technology designed to improve treatment options for critically ill children. The patented technology focuses on a design feature that allows healthcare providers to switch seamlessly between stationary operation and "transport" or "ambulation" mode, enabling unprecedented patient mobility. This innovative feature offers unmatched flexibility, allowing clinicians to tailor treatment plans to the specific needs of each young patient.

09:08 EDT Aquaron Acquisition announces extension of period to consummate combination - Aquaron Acquisition announced that Bestpath IoT has deposited into the company's trust account an aggregate of $20K in order to extend the period of time the company has to complete a business combination for one additional month, from May 6 to June 6. The company issued a promissory note to Bestpath with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the company's shares of common stock at a price of $10.00 per unit at the closing of a business combination by the company. The purpose of the extension is to provide more time for the company to complete a business combination.

09:07 EDT Syla Technologies announces sale of one building of SYFORME - SYLA Technologies announced that its wholly owned subsidiary, SYLA Co. has completed and sold SYFORME SUMIYOSHI II at the end of March. SYLA Co. is dedicated to developing profitable real estate, with a particular focus on Tokyo's 23 wards and the central districts of Yokohama and Kawasaki. Among these areas, SYLA Co. develops its signature condominium brand, the SYFORME series, strategically situated within a 10-minute walking distance from stations, offering convenience for commuters seeking both style and accessibility. Impact on Business Performance The impact of this transaction has already been incorporated in the business forecast for FY2024/12, as announced on January 25, 2024. The Company will promptly disclose any matters that should be announced in the future.

09:06 EDT Regeneron says FDA requested additional analyses during Dupixent sBLA review - In a regulatory filing, Regeneron disclosed that in April 2024, during its review of the company's sBLA for Dupixent in COPD with type 2 inflammatory phenotype, which has a target action date of June 27, 2024, the FDA requested that the company provide additional analyses regarding sub-populations from the BOREAS and NOTUS pivotal studies by the end of May 2024. "While we anticipate providing these additional analyses to the FDA substantially sooner, if the FDA determines that these analyses constitute a major amendment of the sBLA, the FDA's review of the sBLA would be extended by up to three months pursuant to the applicable regulations," the company stated in its 10-Q report. Reference Link

09:06 EDT Fortinet announces updates to generative AI portfolio - Fortinet announced new updates to its generative AI portfolio to enhance both network and security operations, including the industry's first generative AI IoT security assistant. John Maddison, Chief Marketing Officer at Fortinet said, "Generative AI is reshaping network and security operations, supporting IT and cyber professionals to do more, faster. Fortinet is committed to remaining at the forefront of AI innovation, and by expanding FortiAI, our context-aware GenAI assistant, we're continuing to empower operations teams with advanced natural language processing capabilities. The latest updates to FortiAI deliver innovative new ways to interface with Fortinet's products using 30+ common languages to cut through complexity and boost operational efficiency."

09:05 EDT BMO accelerates branch transformation with Matterport digital twins - Matterport (MTTR) announced that BMO (BMO), the eighth largest bank in North America by assets, has leveraged Matterport's digital twin platform to streamline site visits across its physical footprint for multiple areas of the bank. BMO provides a broad range of personal and commercial banking, wealth management, global markets, and investment banking products and services to 13 million customers. In December 2021, BMO announced its plans to acquire Bank of the West. Part of that process included transforming 503 BOTW retail branches to BMO, each of which required rebranding and technology updates.

09:04 EDT N2OFF's NTWO OFF reach milestone to mitigate agriculture's environmental impact - N2OFF announced that its subsidiary NTWO OFF has achieved a milestone in its mission to mitigate agriculture's environmental impact. A recent study conducted by NTWO OFF Ltd.'s research team has demonstrated remarkable success in its goal of reducing nitrous oxide emissions from wheat crops. The study transitioned from growth chambers to open greenhouse environments, allowing for larger pots and soil volumes. This adaptation facilitated the cultivation of more plants per pot and extended growth periods. The results exceeded expectations, with N2O emissions reduced by up to 54% compared to NTWO OFF Ltd.'s previous study methods. "We are thrilled by the outstanding performance of our innovative bacteria under open greenhouse conditions. The successful transition from the lab to an open greenhouse environment is a leap forward in our efforts to develop solutions for the reduction of N20 emissions in agriculture" said Dr. Dror Minz, of the ARO Volcani Institute and head of the research team.

09:03 EDT Mountain Crest Acquisition V enters non-binding term sheet with CUBEBIO - Mountain Crest Acquisition Corp. V and CUBEBIO announced that the parties entered into a non-binding term sheet on April 26, 2024 for a proposed business combination through which CUBEBIO plans to become a public company with its securities listed on The Nasdaq Stock Market. Mountain Crest V is the fifth vehicle in the Mountain Crest family of SPACs, the management of which has successfully completed four prior SPAC business combinations. Based on the non-binding term sheet, the pre-transaction equity value of CUBEBIO for the proposed business combination is $620 million, subject to adjustment depending on additional due diligence by Mountain Crest V and market conditions. Global Fund LLC, a Washington D.C.-based advisory firm specializing in SPAC and DeSPAC transactions in the U.S., has been engaged by CUBEBIO to advise CUBEBIO in connection with the proposed business combination.

09:02 EDT Hovnanian and GTIS Partners expand homebuilding JV with eight communities - Hovnanian Enterprises and GTIS Partners, a global real estate investment firm with a focus on residential and industrial/logistics investments, have expanded their partnership to develop, construct and sell homes in a new joint venture of eight additional for-sale homebuilding communities. To date, the partners have invested in approximately 70 homebuilding communities through multiple joint ventures. The eight newly added communities comprise 1,392 homes located across New Jersey, Florida, Delaware, and South Carolina. Approximately $115M of capital will be invested in the joint venture, with Hovnanian contributing 30% of the capital requirement and GTIS Partners providing 70%, with total build out costs projected at approximately $800M. Hovnanian will manage the day-to-day operations of the venture.

08:55 EDT Oracle's Cloud Infrastructure adopted by TIM in Italy - Oracle and TIM announced a collaboration to support the increasing demand for cloud services in Italy from public and private sector organizations. As part of the agreement, TIM's business unit dedicated to businesses and the public sector, TIM Enterprise, will integrate Oracle Cloud Infrastructure into its portfolio. In addition, TIM will become the host partner for Oracle's second planned cloud region in Italy, which will be located in Turin and hosted in TIM Group's reliable, next-generation datacenter. The upcoming Oracle Cloud Turin Region will provide public and private sector organizations access to a range of cloud services to migrate workloads from their data centers to OCI, modernize their applications, and innovate with data, analytics, and AI. As part of the agreement, TIM Enterprise will offer OCI services to its public and private sector customers across the region, leveraging its long-standing experience in helping customers in any industry migrate their mission-critical workloads to the cloud.

08:55 EDT Mountain Crest Acquisition Corp V trading halted, news pending

08:53 EDT Wayfair Q2 gross margin 30%-31% - Says category showed signs of improvement in late February and March. Says suppliers have diversified to other parts of Asia other than China. Says confident can navigate any pressure from tariffs. Says Q1 will represent a low point for gross margin in 2024. Sees Q2 advertising 11.5%-12.5% of revenue. Sees Q2 adjusted EBITDA margin in mid-single digit range. Sees Q2 cash flow generation considerable. Comments and guidance taken from Q1 earnings conference call.

08:51 EDT LQR House reports 380% y/y revenue growth in April - LQR House announces a 380% year-over-year increase in revenue for April 2024 compared to the corresponding period in 2023. In April 2023, LQR House reported revenues of $49,485.00, while in April 2024, the Company experienced another surge with revenue reaching $237,673.19 for the month. The Company believes that these results reflect LQR House's commitment to growth and development in its niche market. Commenting on this milestone, Sean Dollinger, CEO of LQR House, remarked, "Witnessing our revenue numbers grow from 2023 to what we're reporting in 2024 is truly gratifying. We always believed that we were onto something special with our niche ecommerce platform in such a high-growth sector, but it's immensely rewarding to see this growth materialize. We have other exciting updates in store. We're thrilled about previously announced upcoming launch of our NFT platform. We cannot wait to unveil it to our customers and stakeholders."

08:47 EDT Vicinity Motor secures VMC 1200 distribution agreement with RJames - Vicinity Motor has signed a new distribution agreement with RJames Management Group Ltd to launch RJames Vicinity Truck, a new Vicinity dealership in British Columbia. RJames Management spun off from a family dealership selling heavy trucks to form a leading, full-service commercial truck dealer group. RJames Management also represents Western Star, Freightliner and AutoCar through its six locations across Western Canada. With the opening of RJames Vicinity Truck, RJames Management will expand its well-established commercial truck business into the critical last-mile class 3 electric truck segment. Per the terms of the agreement, RJames Vicinity Truck will distribute Vicinity VMC 1200 vehicles throughout the regions of Kamloops and Kelowna in British Columbia, Canada.

08:45 EDT Blackwells files definitive proxy statement for Ashford Hospitality meeting - Blackwells Capital and Blackwells Onshore I, collectively own 1,000 shares of Ashford Hospitality Trust and have filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its campaign urging stockholders to vote "AGAINST" the election of Monty J. Bennett, Amish Gupta, J. Robison Hays, III, Kamal Jafarnia, David W. Johnson, Frederick J. Kleisner, Sheri L. Pantermuehl, Davinder "Sonny" Sra and Alan L. Tallis to the Company's Board of Directors at the Company's 2024 annual meeting of stockholders, which is scheduled to be held on May 14, 2024. Jason Aintabi, Chief Investment Officer of Blackwells Capital LLC, said: "It is clear to us that Ashford stockholders have suffered from a disasterous stock price performance, abysmal corporate governance and what appears to be a self-dealing external advisory agreement that makes Montgomery Bennett rich at the expense of stockholders. The Board must be held to account for its failure to act as independent fiduciaries. In our opinion, the Board, at best, lacks the necessary skills and acumen and, at worst, could face personal liability for rubber-stamping Mr. Bennett's unchecked parade on Ashford's coffers. Stockholders have an opportunity to send a clear and resounding message to the Board by voting "AGAINST" the election of the incumbent directors at the 2024 Annual Meeting."

08:43 EDT Cloverleaf Local School District conducts online auctions on GovDeals - The Cloverleaf Local School District of Medina County, Ohio, is currently conducting its first set of online auctions for contents from its middle school and annex buildings. The contents will be sold on GovDeals, the leading online marketplace for government agencies and educational institutions to sell real estate and other surplus assets. The auctions are running now and will be open for bidding until May 21. Auctions include contents from several classrooms as well as library items, grounds equipment and kitchen equipment. Pickups for buyers will be held from May 28 to May 30 beginning at 7:30 a.m. until 3:00 p.m. ET. The Cloverleaf Local School District will conduct a second round of auctions for items from their high school from June 6 to June 19. Pickups for these items will be held from June 24 to June 28 from 7:30 a.m. to 3:00 p.m.

08:42 EDT KULR lends battery production infrastructure for support of NASA's R5 program - KULR Technology announced the Company recently leveraged its battery production capabilities at its newly instituted Webster, Texas facility to support NASA with rapid technical aid and production assistance to help prepare the administration's R5 flight battery for its quickly approaching Firefly mission. R5, or "Realizing Rapid, Reduced-cost high-Risk Research", refers to CubeSats designed to operate in Low Earth Orbit at an affordable cost. Project objectives require the R5 teams to rely on commercial-off-the-shelf components whenever possible. More information about the R5 program and its strategy can be found here. A recent round of testing revealed that the battery design required a more robust electrical interconnect to supplement the COTS nature of the design. Within six hours of engagement, the KULR team was able to provide NASA's R5 Team with a solution which successfully passed additional testing the following week. This engagement in particular highlights the collaborative spirit and mindset that drives the Company's Webster, Texas facility where the singular goal is to provide rapid turnaround energy storage solutions, whether it be for KULR's commercially marketed KULR ONE Space platform or something entirely customized, such as NASA's R5 program. KULR's current facility infrastructure was designed and built upon a goal of providing a holistic approach to battery design in the form of KULR ONE Design Solutions. With K1-DS, KULR can provide in-house and custom battery Design, Testing Services, Analysis/Modeling, Abuse Testing, Cell-Level Characterization and Cycling, Fabrication, and Production Services, all in-one-shop.

08:39 EDT Safe & Green announces collaboration, sales of modular units to Britten - Safe & Green Holdings announces its collaboration and sales of modular units to Britten. In addition, the units have received AC 462 Evaluation Service Report designation by the International Code Council, which help codify and expedite jurisdictional approvals and code compliance with regards to shipping containers. "We are thrilled to begin this partnership with Britten, given their expansive customer base and creative use of our modular units for a broad array of business solutions," said Paul Galvin, Chairperson and CEO of Safe and Green Holdings. "Our certified modular units are designed to meet the highest standards of safety and efficiency. We look forward to expanding our relationship with Britten and exploring new frontiers in sustainable building solutions. This AC 462 certification not only reassures clients and code officials but also facilitates better pricing and time utilization for all stakeholders involved in construction and creative projects."

08:38 EDT EpicQuest Education signs four agreements to increase enrollment - EpicQuest Education has entered into four agreements intended to increase enrollment and revenue at its owned and operated schools, EduGlobal College and Davis University. The two MOUs between EEIQ's EduGlobal College and Davis University and Saint Paul International Academy stipulates that both EduGlobal and Davis will engage in marketing and recruiting to propel the online dual degree initiative of the Saint Paul program. This entails EEIQ's two schools recruiting globally for this program, as well as to provide academic and English language support for students seeking to apply to St. Paul High School's dual degree program. The dual degree program will enable high school students from around the globe achieve an international high school diploma from the US. It also represents an opportunity for EduGlobal and Davis to recruit these students for admission to their schools upon completing the program. The two MOUs' terms are for five years from the date of the signing. The two MOUs between EduGlobal and Davis and Hetu Education are intended to recruit transfer students and aims to improve the grade point averages of current university students. Hetu Education will be responsible for marketing the two programs at EduGlobal and Davis to students who hold Chinese citizenship and study permits in the US and Canada. The two MOUs' terms are from April 15, 2024 to August 31, 2027, subject to a 90-day termination right by either party.

08:37 EDT Electrical distributor launches Bridgeline's HawkSearch on Optimizely - Bridgeline Digital announced that an electrical distribution leader has implemented Bridgeline's AI-powered search technology, HawkSearch, to power their eCommerce site on the Optimizely platform.

08:35 EDT MSA Safety increases quarterly dividend 8.5% to 51c per share - MSA Safety increased the quarterly dividend by 8.5% from 47c per common share to 51c per common share. The dividend is payable on June 10, 2024 to shareholders of record on May 15, 2024.

08:25 EDT Stronghold Digital Mining trading halted, news pending

08:22 EDT SOBR Safe signs behavioral health customer, reseller agreement - SOBR Safe has signed a hardware/software agreement with a three-facility behavioral health provider, and a reseller agreement with a new channel partner servicing the justice, workplace safety and family law markets. Based in Southern California, the customer1 provides the full continuum of care, from inpatient detoxification and residential treatment to outpatient services. The customer purchased and has now installed a SOBRcheck device in each of its three facilities to enable point-of-care screening. Based in San Antonio, Texas, Alcohol Monitoring Solutions DBA2 365IID has purchased an initial three SOBRcheck devices and two SOBRsure wearable wristbands, and intends to place an additional order for both in the next 30 days. 365IID is presenting the SOBRsafe technology in the San Antonio and El Paso areas for pre-trial and Drug Court applications, and for workplace safety in warehouses. SOBRsafe has now secured 18 new accounts in 2024, compared to three accounts booked in all of 2023.

08:20 EDT Blink Charging secured contract as official EV charging provider for New York - Blink Charging has announced it has secured a contract as an official EV charging provider for the state of New York. The agreement sets the stage for Blink Charging and New York to electrify state and municipal fleets and public charging solutions for employees, residents, and visitors. "The state of New York and Blink are focused on leading the electrification of transportation together," states Jim Nemec, Chief Revenue Officer at Blink Charging. "As we set our sights on providing holistic, targeted charging options for EV drivers throughout New York state and the world, we'll continue to lay the groundwork for an electric revolution. It's rewarding to have a direct role in reducing emissions while enhancing the EV driver experience in New York. We are grateful for the state's trust and our shared vision."

08:19 EDT Immutep announces initial data from EFTISARC-NEO - Immutep announces initial data from EFTISARC-NEO, a Phase II investigator-initiated trial of eftilagimod alpha in combination with radiotherapy, a standard-of-care treatment, plus KEYTRUDA for patients with soft tissue sarcoma, STS. The EFTISARC-NEO study is the first to evaluate efti in a neoadjuvant setting, which takes place before intended surgery, and the first to combine efti with radiotherapy. Importantly, the neoadjuvant setting allows for the impact of this novel combination to be assessed in the tumour microenvironment, TME. The triple combination has revealed no new safety findings and has been well tolerated in the first six patients who have completed the 10 weeks of treatment followed by surgery 2-3 weeks later. Initial efficacy data is very encouraging with 4 of 6 patients having near-complete responses according to EORTC-STBSDG, which measures responses via tissue pathology after surgery. These deep responses are rarely seen in STS patients with standard therapeutic approaches including radiotherapy.

08:18 EDT Provectus announces notice of allowance for US patent on RBS - Provectus Biopharmaceuticals announced that the United States Patent and Trademark Office has allowed patent application 17/232,393, titled "Halogenated Xanthene Composition and Method for Treating Hematologic Cancers". The application covers the use of Provectus's pharmaceutical grade rose bengal sodium, RBS, active pharmaceutical ingredient for the single agent or combination therapy treatment of pediatric and adult leukemias. Earlier this year, Provectus announced notices of allowance and award for U.S. patents of RBS in virology, pediatric solid tumor cancers, and vaccines. Dominic Rodrigues, President and Vice Chairman of Provectus's Board of Directors said, "As we remain focused on advancing intratumoral administered cancer immunotherapy PV-10 towards initial drug approval for metastatic pancreatic cancer, our evidence-based confidence in the potential and possibilities of oral administration of rose bengal sodium for the treatment of disease continues to grow."

08:17 EDT Palatin's IND application for obesity candidate granted FDA clearance - Palatin announced that the FDA has completed its 30-day review of the investigational new drug - IND - application for the use of bremelanotide, a melanocortin receptor 4 agonist for the treatment of obesity. The company is cleared to begin enrollment in a Phase 2 clinical study evaluating the safety and efficacy of bremelanotide, co-administered with tirzepatide in obese patients. The Phase 2 clinical study is expected to start mid-calendar year 2024, with topline data results by the end of calendar year 2024.

08:16 EDT TeraWulf self-mined 348 bitcoin in April - TeraWulf provided an unaudited monthly production and operations update for April 2024. April 2024 Production and Operations Highlights: Self-mined 348 bitcoin in April with an average production rate of 11.6 bitcoin per day. Power cost averaged $16,058 per bitcoin self-mined, or approximately $0.038/kWh in April, which excludes the benefit of expected demand response or ancillary services proceeds. Remaining older generation miners at Lake Mariner were replaced with approximately 3,000 S19k Pro miners in April bringing Lake Mariner's total S19k Pro miner count to approximately 4,100.

08:15 EDT Mangoceuticals granted 180-day extension to meet Nasdaq minimum bid price - Mangoceuticals announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company now has until October 24, 2024 to meet the requirement. On the same date, Nasdaq provided notice to the Company that based on the Company's April 25, 2024, Current Report on Form 8-K filing, Nasdaq has determined that the Company complies with Nasdaq Listing Rule 5550(b) which requires companies listed on the Nasdaq Capital Market to maintain stockholders' equity of at least $2,500,000. However, Nasdaq also advised that if the Company fails to evidence compliance with the Rule upon filing its next periodic report it may be subject to delisting.

08:14 EDT Akoya, Shanghai KR announce KR-HT5 receive premarket approval from China's NMPA - Akoya Biosciences and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China's National Medical Products Administration, NMPA, to support next generation pathology clinical workflows. The NMPA serves as the national regulatory body in China, overseeing the safety, quality, and efficacy of medical products, encompassing pharmaceuticals and medical devices. Obtaining NMPA approval indicates that the regulatory authority has examined and sanctioned the product for sale or utilization in the Chinese clinical market. The KR-HT5 is a product jointly developed by Akoya Biosciences and Shanghai KR Pharmtech for Chinese clinical needs. Built on the PhenoImager HT core technologies, specifically Akoya's Multispectral Imaging and spectral unmixing technologies, KR-HT5 will provide clinicians with a high-throughput platform to enable analysis for multiplex biomarker workflows. Shanghai KR Pharmtech will offer the KR-HT5 as part of its Next Generation Pathology solutions. "We are honored and excited to collaborate with Shanghai KR Pharmtech to develop KR-HT5 with our PhenoImager HT core technology and launch the Next Generation Pathology initiative," expressed Brian McKelligon, CEO of Akoya Biosciences.

08:13 EDT Dare Bioscience selected as spoke for ARPA-H Investor Catalyst Hub - Dare Bioscience was selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health. As an Investor Catalyst Hub spoke, Dare gains access to potential funding and flexible contracting for faster award execution compared to traditional government contracts. Spoke membership also offers opportunities to provide input on ARPA-H challenge areas and priorities, along with access to valuable networking opportunities and a robust resource library.

08:12 EDT Voip-Pal.com says court denies Huawei's motion for judgement - VoIP-Pal.com announcde that the Northern District of Texas has denied Huawei's motion for judgment on the pleadings in VoIP-Pal.com Inc v. Huawei Technologies Co LTD, 3:23-cv-00151-X. The motion asserted that VoIP-Pal's U.S. Patent Nos. 8,630,234 and 10,880,721, known as the Mobile Gateway patents, claim ineligible subject matter under 35 U.S.C. Section 101. In determining eligibility under Section 101, a court applies a two-part test, commonly known as the Alice test. The Court arrived at its decision at step one, finding that VoIP-Pal's Mobile Gateway patents are not directed to an abstract idea. This ruling in VoIP-Pal's favor is timely as the Company prepares for its upcoming trials scheduled for August 19, 2024, against Verizon and November 4, 2024, against T-Mobile, involving the same Mobile Gateway patents. A pre-trial hearing in those cases is scheduled for July 9, 2024 and July 15, 2024. VoIP-Pal CEO, Emil Malak, said "This is extremely good news. Once again, we have received another positive ruling in one of the many challenges attacking the validity of our patents. Each of those times our patents have stood on their technical merits. I am very grateful to our incredible, expert technical and legal teams that have worked so hard to help get us across the finish line. We are looking forward to having our day in court soon and hopefully bringing our long legal battles to a favorable conclusion. Patience is a virtue."

08:10 EDT IBM expands software availability to 92 countries in AWS Marketplace - IBM (IBM) announced that the availability of its software portfolio is expanding globally to 92 countries in Amazon's (AMZN) AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services, or AWS. The expansion beyond Denmark, France, Germany, U.K. and U.S., where the software is currently available, aims to make procurement easier for clients, streamline purchasing and create new efficiencies, while allowing them to use their AWS committed spend for IBM software purchases. Other software includes IBM's flagship database Db2 Cloud Pak for Data as well as a portfolio of automation software including Apptio, Turbonomic and Instana, and the IBM Security and Sustainability software portfolios - all built on Red Hat OpenShift Service on AWS. The cloud-native software enables clients to deploy on AWS while flexible licensing, including SaaS and subscription, makes it easier for clients to purchase exactly how they want. IBM is also launching 15 new IBM Consulting professional services and assets on AWS Marketplace, exclusively designed for AWS.

08:09 EDT Kellanova backs FY24 free cash flow view ~$1B - Sees FY24: Net cash provided by operating activities of approximately $1.7B, with capital expenditure of about $0.7B, which is elevated this year for the expansion of Pringles capacity in emerging markets. As a result, free cash flow is expected to be approximately $1B.

08:09 EDT Science 37 delivers 22x faster enrollment than traditional methods for trial - Science 37 Holdings disclosed the latest enrollment figures resulting from its Metasite and Patient Recruitment partnership with a leading biotech company whose asthma drug is currently undergoing a Phase 3 clinical trial. Leveraging its proprietary Metasite and Patient Recruitment solutions, Science 37 contributed 28% of all randomized study participants over a 15-month enrollment window. Science 37 averaged 44 patients enrolled per month, while each of the 55 brick-and-mortar sites supporting the trial enrolled an average of two participants per month. Science 37 delivered an enrollment velocity 22x greater than study sites in the trial and reduced the study's overall time-to-target enrollment.

08:07 EDT Dow to sell flexible packaging laminating adhesives unit to Arkema for $150M - Dow (DOW) announced that it has signed an agreement to sell its flexible packaging laminating adhesives business, within Dow's Packaging & Specialty Plastics segment, to Arkema (ARKAY), a leader in specialty materials. Five manufacturing sites in Italy, the United States and Mexico will transfer to Arkema and include Solvent-Based Laminating Adhesives, Solventless Laminating Adhesives, and Heat Seal Coatings product families. The transaction value is $150M or approximately 10 times forecasted 2024 EBITDA. The transaction is expected to close by the end of 2024, subject to regulatory approval. Dow will retain its water-based laminating adhesives and acrylic adhesives businesses in Packaging and Specialty Plastics, as well as adhesive solutions in Dow Consumer Solutions and MobilityScience, which align with the company's market growth strategies.

08:07 EDT Xwell introduces IV hydration drip therapy at MIA - XWELL announced the introduction of IV hydration drip therapy at its Miami International Airport, MIA, XpresSpa location. In partnership with Revitalize IV Lounge, the new service, which offers a fast and efficient way to deliver vitamins, minerals, and amino acids directly into the bloodstream, is available in MIA's North Terminal, Concourse D, Gate D-11. "A popular and effective treatment to replenish our body's essential nutrients, IV hydration drip therapy is a compelling addition to our XpresSpa menu of services and provides yet another opportunity to drive more revenue at higher margins," said XWELL CEO, Scott Milford. "Miami is a great location for us to pilot Revitalize's IV drips, with the intention of expanding to other U.S. markets."

08:05 EDT Taysha Gene Therapies announces RMAT designation granted to TSHA-102 by FDA - Taysha Gene Therapies announced the United States Food and Drug Administration, FDA, has granted Regenerative Medicine Advanced Therapy, RMAT, designation to TSHA-102, a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome. RMAT designation was granted following the FDA's review of clinical data supporting the potential of TSHA-102 to address the unmet medical need for patients with Rett syndrome.

08:04 EDT 60 Degrees receives FDA comments on Tafenoquine-Babesiosis trial protocol - 60 Degrees Pharmaceuticals announced that the U.S. Food and Drug Administration has provided comments on the protocol of a planned clinical trial that will study the use of tafenoquine in treating babesiosis. Babesiosis, a potentially life-threatening disease in immunosuppressed patients, is a tick-borne illness steadily emerging in the United States. The FDA had some questions and recommendations that will be addressed. Nothing in the comments requires the Company to change the trial design/protocol in a material way. The Company is continuing preparatory actions to facilitate initiation of patient enrollment later in 2024. The Company conducted a Type C regulatory meeting with the FDA on January 17, 2024, at which a synopsis of the current version of the tafenoquine for babesiosis study protocol was discussed. In February 2024, the Company submitted a full protocol to the FDA under its malaria Investigational New Drug application, incorporating FDA feedback from the January 17, 2024 meeting. Because the protocol was submitted under an existing IND application per the FDA's advice, no formal statutory response time was required by the FDA. The FDA informed the Company in March 2024, however, that comments on that protocol would be provided by April 30, 2024. The FDA provided this feedback on April 26, 2024. Tafenoquine is approved for malaria prophylaxis in the United States under the product name ARAKODA. The safety of the approved regimen of tafenoquine for malaria prophylaxis has been assessed in five separate randomized, double-blind, active comparator or placebo-controlled trials for durations of up to six months. Tafenoquine has not been proven to be effective for treatment or prevention of babesiosis and is not approved by the FDA for such an indication.

08:02 EDT CME Group reports record April ADV of 26.5M contracts - CME Group reported its April 2024 market statistics, with a new average daily volume - ADV - record of 26.5M contracts for the month, up 33% from April 2023, with double-digit growth across all asset classes. Additionally, interest rate, equity index, foreign exchange and options products set new April ADV records. Metals also reached a new April ADV record, including monthly records for metals options, copper futures and options, and silver options. U.S. Treasury options also reached an all-time monthly ADV record. Other results include record April Interest Rate ADV of 12.6M contracts, record April equity index ADV of 7.6M contracts, record April options ADV of 5.7M contracts, Energy ADV of 2.4M contracts, agricultural ADV of 1.8M contracts, record April Metals ADV of 1M contracts, record April Foreign Exchange ADV of 988K contracts. Customer average collateral balances to meet performance bond requirements for 1Q 2024 were $75.7B for cash collateral and $158.7B for non-cash collateral.

07:56 EDT Acurx presents ibezapolstat Phase 2 clinical trial results in CDI - Acurx announced that results from the ibezapolstat Phase 2 clinical trial in patients with C. difficile Infection - CDI - were presented at the 34th Congress of ESCMID Global on April 30th held in Barcelona. Dr. Eugenie Basseres, Research Scientist, University of Houston College of Pharmacy, stated: "These findings show that ibezapolstat's unique mechanism of activity, inhibition of DNA polymerase IIIC, translates into in vitro activity against C. difficile strains with reduced susceptibility to fidaxomicin and vancomycin. As antimicrobial-resistant strains continue to emerge in the community, ibezapolstat will become a valuable therapeutic option. These data reinforce earlier findings related to the anti-recurrence properties of ibezapolstat and warrant further development in Phase 3 trials with further microbiome studies planned to confirm the mechanisms behind these clinical findings". The complete Phase 2 results are being prepared for submission to a prominent scientific journal.

07:54 EDT Radcom selected to deliver SaaS service assurance solution on AWS - Radcom (RDCM) announced that a U.S. telecom operator has extended its contract to use RADCOM ACE Service Assurance to drive quality and ensure superior customer experiences. As part of this contract extension, RADCOM ACE will run on Amazon Web Services (AMZN) as a Software-as-a-Service. Deploying RADCOM ACE on AWS will enable this operator to achieve high levels of automation and flexibility when using their assurance solution to gain real-time insights into the network and user experience. This allows the operator to adapt quickly to network changes, ensuring excellent customer experiences and delivering top-quality services.

07:53 EDT Driven Brands CFO Gary Ferrera to step down - Driven Brands also announced that Gary Ferrera, CFO, will step down to pursue a professional opportunity at a privately held company and move back to Colorado, where his family is located. Ferrera's resignation will be effective after the filing of the company's quarterly report on Form 10-Q for the first quarter of 2024. Driven Brands has initiated a search with the assistance of an executive recruitment firm to identify Ferrera's successor. Effective upon Ferrera's departure, Joel Arnao, senior VP of FP&A, treasury and investor relations, has been appointed as interim CFO.

07:52 EDT Nextech3D.AI announces 3D AI modeling profit margins hitting 80% in Q2 - Nextech3D.AI announced a major milestone in its 3D modeling business for ecommerce by hitting 80% gross profit in Q2, 2024 which is up 166% from 30% in 2023. This milestone achievement is only possible through the company's investment in AI and its pivot to Hyderabad India in Q3, 2023. The company said, "The company believes that it can become profitable in 2024 by scaling revenue with 80% profit margins while operating expenses are going down due to its investment in its patented AI. The strategic shift to Hyderabad India aligns perfectly with Nextech3D.ai's commitment to delivering top-tier 3D modeling and augmented reality solutions while maintaining a keen eye on profitability and fiscal responsibility for its valued shareholders."

07:51 EDT Chemours discontinues U.S. sales of legacy freon refrigerants 404A and 507 - The Chemours Company announced its strategic decision to cease sales of Freon 404A (R-404A) and Freon 507 (R-507) in the United States. Chemours-the inventors of Freon and Opteon(TM) refrigerant portfolios -will discontinue U.S. sales of these select Freon products as of May 2, 2024, in support of regulatory phasedown requirements.

07:47 EDT Penn Entertainment confirms hiring of Aaron LaBerge as CTO - "To accelerate our technology and product improvements, we recently announced the hiring of Aaron LaBerge as the Company's Chief Technology Officer," said Penn Entertainment (PENN) CEO Jay Snowden. "Mr. LaBerge brings more than 20 years of experience at The Walt Disney Company, most recently serving as the CTO for both Disney Entertainment (DIS) and ESPN. In his new role, he will be responsible for driving technology strategy and execution for PENN, while leading a multinational team of technologists and serving as the key business leader for the Company's Interactive division. We are incredibly excited about the arrival of Mr. LaBerge, who is uniquely qualified to help us create a best-in-class digital experience for our customers, while further deepening our connections and integrations with ESPN.

07:44 EDT Clubhouse Media announces HoneyDrip.com results for April - Clubhouse Media Group announced that HoneyDrip.com has seen month over month growth, continuing into April 2024. Honeydrip.com is a digital platform designed and wholly owned by CMGR with a focus on the empowerment of creators. The site allows creators to connect and engage with fans and monetize exclusive content. HoneyDrip.com has experienced rapid growth in four main categories during the month of April 2024 alone: 1) Active performers on the site increased by 3%; 2) Content posts to be sold increased by 5%; 3) Active users increased by 4%; 4) Applications from creators wishing to join the site increased by 2%

07:43 EDT Guru Organic Energy launches new GURU Zero Wild Berry - GURU Organic Energy announced the official launch of its new ZERO SUGAR category, starting with its mesmerizing GURU Zero Wild Berry. Carl Goyette, President and CEO of GURU stated: "With the new GURU Zero line, we're targeting a new, fast-growing trend of consumers who are looking for energy drinks that can boost their metabolism without compromise: ZERO SUGAR, ZERO SUCRALOSE, ZERO ASPARTAME AND ZERO ARTIFICIAL INGREDIENTS. Through our leading-edge R&D capabilities, GURU has once again hit the mark with another great tasting natural energy drink with a new functionality that supports active lifestyles and improved physical performance."

07:43 EDT Theratechnologies to present data on use of TH1902 at 2024 ASCO meeting - Theratechnologies announced that it will present long-term efficacy, safety and pharmacokinetic data on the use of its lead investigational peptide-drug conjugate candidate, TH1902, in patients with solid tumors. The Company will present the long-term data in a poster session at the 2024 American Society of Clinical Oncology, ASCO, Annual Meeting, which takes place May 31-June 4, 2024, in Chicago, IL. The ASCO poster represents the first presentation of long-term data from Part 1 and Part 2 of Theratechnologies' Phase 1 clinical trial of sudocetaxel zendusortide in individuals with solid tumors, following preliminary evidence of antitumor activity presented at the 2023 ASCO annual meeting. This updated analysis will present further data on long-term efficacy, safety and PK from Parts 1 and 2, focusing specifically on patients receiving sudocetaxel zendusortide at a dose of 300 mg/m2 every three weeks. Patients in this dosing group have cancers with known high expression of sortilin, including ovarian cancer, endometrial cancer, triple-negative breast cancer and melanoma. Part 3 of the Phase 1 trial, in patients with advanced ovarian cancer, is ongoing.

07:41 EDT Xos receives approval from CARB for 2024 Electric Stepvan to be listed on HVIP - Xos has received official approval from the California Air Resources Board, CARB, for the 2024 Xos SV Battery Electric Stepvan to be listed on the Clean Truck and Bus Voucher Incentive Program, HVIP, catalog. The HVIP incentive, starting at a base amount of $85,000, offers Xos a significant opportunity to provide their innovative 2024 Xos SV Battery-Electric Stepvan at a reduced upfront cost to customers.

07:39 EDT Biogen reports progress on Corporate Responsibility Priorities - Biogen announced publication of its 2023 Corporate Responsibility Report detailing progress on the company's commitment to making responsible business decisions in the best interests of all its stakeholders. "As we reflect on the past year and set our sights on the path ahead, I am truly inspired by the progress we have made to advance Biogen's enduring legacy of pioneering innovative science to deliver medicines that transform patients' lives and create value for our communities and our shareholders," said Christopher A. Viehbacher, Biogen President and Chief Executive Officer. "Our mission and business strategy are grounded in our commitment to responsible business, and in 2023, we refined our corporate responsibility strategy to advance our evolving business priorities and align with areas where we believe we can have the greatest impact."

07:38 EDT Context announces FDA clearance of IND application for Phase 1 trial of CTIM-76 - Context Therapeutics announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application for CTIM-76, a Claudin 6 x CD3 T cell engaging bispecific antibody. The IND supports the initiation of a Phase 1 dose escalation and expansion clinical trial of CTIM-76 in patients with CLDN6-positive gynecologic and testicular cancers. The Company anticipates the enrollment of the first patient in the dose escalation portion of its clinical trial in mid-2024. "The FDA's clearance of our IND marks an important achievement for Context, allowing us to proceed with the Phase 1 clinical program for this potentially best-in-class CLDN6-targeting therapy," said Martin Lehr, CEO of Context. "We look forward to the expected dosing of the first patient with CTIM-76 in the coming months, and we believe the Company is well-positioned to achieve key program milestones."

07:32 EDT Avidian Gold to sell Alaskan subsidiary to Contango Ore - Avidian Gold has entered into a binding Stock Purchase Agreement with Contango ORE, pursuant to which Contango has agreed to purchase Avidian's 100% owned Alaskan subsidiary, Avidian Gold Alaska for initial consideration of $2.4 million, plus a potential future upside consideration of $1.0 million, for a total consideration of up to $3.4 million. The consideration is a combination of cash plus Contango shares. Avidian Alaska owns and controls the Golden Zone and Amanita NE gold properties and has an option agreement to purchase 100% of the Amanita gold property. Golden Zone is a large, prospective property in between Anchorage and Fairbanks near rail and highway infrastructure. The Amanita and Amanita NE gold properties border Kinross Gold Corporation's Fort Knox operation near Fairbanks. Transaction Details Contango to acquire 100% of the capital stock of Avidian Gold Alaska Inc. from Avidian Gold Corp.; Contango will pay Avidian an initial purchase price of $2,400,000 consisting of $400,000 in cash and $2,000,000 in shares of Contango common stock. The Cash Consideration shall be paid in the following tranches: a deposit $50,000, $150,000 due on the Closing Date, and $200,000 due on or before the 6-month anniversary of the Closing Date. The number of shares of common stock constituting the Equity Consideration will be determined based on Contango's NYSE-A, 10-day volume-weighted average price immediately prior to the Closing Date; If Contango makes a positive production decision on either of the Amanita or Golden Zone properties within 120 months of the Closing Date, Contango will pay Avidian an additional US$1,000,000 within thirty days of such decision. The Deferred Purchase Price can be paid in either cash or shares of Contango at Contango's sole discretion. If at any time prior to this production decision, within the 120-month period, Contango enters into a third party transaction on either of the Amanita or Golden Zone properties, Avidian will receive 20% of the consideration received by Contango, to be credited against the total Deferred Purchase Price; and The Transaction is subject to Avidian Shareholder approval, as well as the receipt of all required governmental and/or regulatory approvals, including that of the Toronto Venture Exchange and NYSE-A. Should Avidian Shareholders not approve this transaction the Agreement will terminate and a termination fee of US$175,000 will be paid to Contango, representing liquidated damages for the time, resources and opportunities lost in facilitating this transaction. Both Avidian's and Contango's Board of Directors have unanimously approved the Transaction. The Board of Directors for Avidian unanimously recommends that shareholders vote in favor of the Transaction. The Annual General and Special Meeting of shareholders will be held on July 4, 2024. It is expected that closing of this Transaction will happen as soon as practically possible following the shareholder meeting that has approved the Transaction.

07:29 EDT Arbutus Biopharma announces retirement of CSO Sofia - Arbutus Biopharma announced that after a distinguished 38-year career, the Company's co-founder and Chief Scientific Officer, CSO, Dr. Michael Sofia, will retire effective December 31, 2024.

07:27 EDT Pluri launches novel immunotherapy platform, announces appointments to SAB - Pluri launched its placental allogeneic MAIT cell platform for immunotherapy treatment for solid tumors. Pluri recently unveiled a novel method for expansion of immune cells as well as a new U.S. granted patent. Pluri believes that the newly announced immunotherapy platform can revolutionize solid tumor treatment and unlock the potential of placental MAIT cells, which are unique immune cells derived from healthy donors. The Company also announced that Dr. Prasad S. Adusumilli and Dr. Richard L. Kendall, two renowned oncology researchers, joined its newly formed Scientific Advisory Board, SAB, to provide strategic counsel as this project advances.

07:26 EDT BridgeBio launches BBOT with $200M of private external capital - BridgeBio Pharma has announced the completion of a $200M private financing of its former subsidiary, TheRas, Inc. d/b/a BridgeBio Oncology Therapeutics, BBOT, to accelerate the development of its oncology portfolio. The oversubscribed financing was led by Cormorant Asset Management and co-led by Omega Funds with participation from affiliates of Deerfield Management, GV, EcoR1 Capital, Wellington Management, Enavate Sciences, Surveyor Capital, Aisling Capital, Casdin Capital, and Longwood Fund. BBOT will be advancing three initial programs: BBO-8520, a direct inhibitor of KRASG12C that binds to both the ON and OFF states of the protein; BBOT is currently enrolling patients in the ONKORAS-101 trial for patients with KRASG12C mutant non-small cell lung cancer; BBO-10203, a PI3Kalpha:RAS breaker that blocks the specific interaction between RAS and PI3Ka to inhibit PI3Kalpha / AKT effector signaling in tumors while bypassing glucose metabolic signaling to avoid hyperglycemia; BBOT expects to file an Investigational New Drug application for BBO-10203 in Q2 2024 and, subject to clearance of the IND, will begin enrolling patients later this year; BBO-11818, a pan-KRAS inhibitor that targets both the ON and OFF states of KRASG12X for which BBOT expects to file an IND in early 2025

07:24 EDT PyroGenesis announces results of lab strength tests for green cement additive - PyroGenesis Canada has been advised by its client, Progressive Planet, that the latest series of compressive strength tests on its PozPyro green cement additive product reveal impressive results, posting strength comparisons significantly above the acceptable standard for similar material. PozPyro enhances the strength of concrete as a replacement for fly ash, which is in diminishing supply. PozPyro, a cement alternative, is being developed in collaboration with Progressive Planet as a supplementary cementing material designed to partially replace traditional Portland Cement. Of note, Portland Cement emits substantial amounts of CO2 during its production. PozPyro, on the other hand, is created by using a PyroGenesis plasma-based process that transforms quartz silica, a widely available material, into a SCM, without off-gassing CO2 during the production process. This innovation comes at a time when the cement industry seeks more sustainable practices without compromising quality or performance. "Quartz silica is one of the most abundant materials in the earth's crust," said P. Peter Pascali, President and CEO of PyroGenesis. "The ability to economically convert it into PozPyro could offer a new supply of material to compensate for the diminishing supply of fly ash, a common SCM, which, by the way, is generated by the same coal fired power plants which are being targeted for shut down in Canada by 2030." The workability of cement is measured by water demand and is a measure of its ease of use in various concrete applications. The smaller the water demand number, the better the reading. A passing water demand number must be less than 115% of the water demand of the control mix. The water demand for PozPyro was between 99% and 109% for all test batches and as such PozPyro demonstrated excellent workability. STRENGTH ACTIVITY INDEX: The SAI is an industry standard for measuring the compressive strength of cement mortar cubes. As announced in a press release on April 11, 2024, the results of the 7-day testing that showed an approximate average +45% SAI gain across four tests against the minimum target value. In the 28-day tests announced today, Portland Cement was used as the control product, with varied compressive strengths between 35.26 and 39.62 megapascals depending on the test. These tests were conducted in two series, A and B, with two tests in each series, using different input variables to test for optimized results.

07:23 EDT Criteo raises FY24 guidance - "We now expect Contribution ex-TAC to grow high-single-digit at constant currency, compared to our previous guidance of mid-single-digit growth at constant currency. We now expect an Adjusted EBITDA margin of approximately 31% of Contribution ex-TAC, compared to our previous guidance of 29% to 30% of Contribution ex-TAC."

07:20 EDT FactSet raises quarterly cash dividend 6% to $1.04 per share - FactSet announced that its Board of Directors approved a 6% increase in the regular quarterly cash dividend of $0.98 per share to $1.04 per share.

07:19 EDT Blueprint Medicines sees FY24 AYVAKIT net product revenues $390M-$410M - Blueprint Medicines now anticipates approximately $390 million to $410 million in global AYVAKIT net product revenues for all approved indications in 2024, an increase from the previous range of $360 million to $390 million. This updated guidance reflects continued execution in the global launch for ISM, as well as a stronger than anticipated first quarter. The company continues to expect that full-year operating expenses and cash burn will decline in 2024 as compared to 2023, and that its existing cash, cash equivalents and investments, together with anticipated future product revenues, will enable the company to maintain a durable capital position to achieve a self-sustainable financial profile. FY24 revenue consensus $392.12M.

07:14 EDT Wendy's reports Q1 global SSS up 0.9% - Reports Q1: Global same-restaurant sales growth 0.9%; U.S 0.6%; International 3.2%."

07:07 EDT Kymera Therapeutics sees cash runway into 1H27 - As of March 31, 2024, Kymera had approximately $745 million in cash, cash equivalents, and investments. Kymera expects that its cash and cash equivalents will provide the Company with an anticipated cash runway into the first half of 2027. Its existing cash is expected to take the Company beyond the Phase 2 data for KT-474, as well as additional proof-of-concept data for KT-253 and KT-333, and several clinical inflection points for its STAT6 and TYK2 programs while Kymera continues to identify opportunities to accelerate growth and expand its pipeline, technologies and clinical indications.

07:05 EDT Frontier Group sees FY24 capacity growth 12%-15% - Sees FY24 average fuel cost per gallon $2.80-$2.90. Sees FY24 adjusted CASM down 1%-3%. Sees FY24 pre-tax margin 3%-6%. The company said, "Full-year guidance is unchanged from February 6, 2024 with the exception of fuel prices. To recap, capacity is expected to be 12 to 15 percent higher compared to 2023 and adjusted (non-GAAP) pre-tax margin is expected to be 3 to 6 percent (excluding special items). Fuel costs are now expected to be $2.80 to $2.90 per gallon based on the blended fuel curve on May 1, 2024, $0.10 per gallon higher than previous guidance. Adjusted (non-GAAP) CASM (excluding fuel), stage-length adjusted to 1,000 miles, is expected to be down 1 to 3 percent over the prior year. Pre-delivery deposits, net of refunds, are expected to be $20 to $50 million and other capital expenditures are expected to be $160 to $180 million."

07:04 EDT Frontier Group sees Q2 capacity growth 12%-14% - Sees Q2 adjusted operating expenses $705M-$720M. Sees Q2 average fuel cost per gallon $2.80-$2.90. Sees Q2 effective tax rate 23%. Sees Q2 adjusted pre-tax margin 3%-6%.

07:01 EDT Peloton CEO Barry McCarthy stepping down - Peloton Interactive announced Barry McCarthy is stepping down as President, CEO and a Peloton Board Director, and will become a strategic advisor to Peloton through the end of the year. The Board has initiated a comprehensive search process to identify Peloton's next CEO. Karen Boone, current Peloton Chairperson, and Chris Bruzzo, a Peloton Director, will serve as Interim Co-CEOs. In addition, Jay Hoag, a Peloton Director, has been named the new Chairperson of the Board.

06:38 EDT KBR awarded $34M Navy contract - KBR announced it has been awarded an estimated $34M recompete cost-plus-fixed-fee single award IDIQ contract by the U.S. Naval Research Laboratory for facility operations, maintenance and security in Washington, D.C. over a five-year period. Under the terms of the new contract, KBR's scope and services will expand to incorporate staffing the NRL visitor's center and cybersecurity support at multiple NRL campuses to maintain data integrity. KBR will also provide maintenance and sustainment of two controlled areas in Washington, D.C., including retrofitting space for incoming tenants supporting research.

06:36 EDT Moderna sees initial regulatory approvals of RSV vaccine in 1H24 - The company anticipates initial regulatory approvals of its RSV vaccine beginning in the first half of 2024. Moderna is targeting fall 2024 for its U.S. RSV vaccine launch.

06:34 EDT Regeneron lowers FY24 CapEx view to $780M-$880M from $825M-$950M

06:32 EDT Marpai implements cost reduction program, subleases property - Marpai announced the implementation of a cost reduction program and the sublease of one of its properties. These initiatives are expected to generate $3M in annual savings and position the company for continued financial strength. The cost reduction program, developed by Marpai's leadership team, identifies and implements strategic measures to streamline operations and optimize expenditures. This program is anticipated to yield approximately $3M in annual savings across various areas of the business. In addition to the cost reduction program, Marpai has successfully subleased one of its properties. This strategic move frees up capital and reduces ongoing operational costs associated with the property.

06:28 EDT Wesco raises FY24 free cash flow view to $800M-$1B

06:24 EDT Shutterstock to acquire Envato for $245M - Shutterstock announced that it entered into a definitive agreement to acquire Envato. Founded in 2006 and headquartered in Australia with a presence in Mexico and New Zealand, Envato enables millions of people around the world to buy and sell creative assets, use smart design templates and learn skills. The transaction consists of $245M cash purchase of 100% of Envato at closing, after customary working capital and other adjustments. Th transaction is expected to accelerate path to Shutterstock's 2027 long-term targets with Envato adding 20% to annual revenues and 15% to annual adjusted EBITDA. Financing via a $375M credit facility with expected drawn leverage of 0.7x net debt to 2024 combined adjusted EBITDA Expected transaction closing in the third quarter, subject to customary closing conditions.

06:17 EDT Murphy Oil backs FY24 CapEx, production guidance - Murphy maintains its 2024 accrued CAPEX range of $920M-$1.02B. The company also maintains its full year 2024 production range of 180 to 188 MBOEPD, consisting of approximately 95 MBOPD oil and 105 MBOEPD liquids volumes, equating to 52 percent oil and 57 percent liquids volumes, respectively. Production for second quarter 2024 is estimated to be in the range of 176 to 184 MBOEPD with 93 MBOPD, or 51 percent, oil volumes. This range is impacted by 2,000 BOEPD of offshore non-operated unplanned maintenance, 1,250 BOEPD of Eagle Ford Shale planned downtime and 11,700 BOEPD of Tupper Montney planned plant maintenance. Both production and CAPEX guidance ranges exclude Gulf of Mexico NCI.

05:20 EDT ArcelorMittal sees FY24 capital expenditures $4.5B-$5B - The company said, "Overall economic sentiment remains subdued with customers maintaining a "wait and see" approach with no restocking yet apparent. Nevertheless, sentiment appears to have reached a floor and given the low inventory environment (particularly Europe) as soon as real demand begins to gradually improve, apparent demand is expected to rebound. The Company continues to forecast World ex-China apparent steel consumption ("ASC") to grow +3.0% to +4.0% in 2024, including: +1.5% to +3.5% in US; +2.0% to +4.0% in Europe; +0.5% to +2.5% in Brazil and +6.5% to +8.5% in India. The Company remains positive on the medium/long-term steel demand outlook and believes that it is optimally positioned to execute its strategy of growth with capital returns. Capex in 2024 is expected to remain within the $4.5-$5.0 billion range (of which $1.4-$1.5 billion is expected as strategic growth capex)."

05:14 EDT Shell backs FY24 capital expenditures view $22B-$25B

05:07 EDT Sasol CFO Hanre Rossouw to step down - Shareholders are advised that Hanre Rossouw has informed the company that he will step down as CFO and executive director of Sasol Limited on October 31. Hanre will remain with Sasol for the financial year-end closing and the publication of their suite of annual reports for the year ending June 30, allowing for a structured handover period. Sasol has commenced the succession process and an announcement will be made in due course.